Lupin Pharmaceuticals is recalling more than 2.5 million bottles of steroid eye drops after a possible foreign-material concern was identified. The action puts consumers, pharmacies, retailers, and drug-safety regulators in the same safety response.

A recall can remove potentially affected medicine from circulation, while stronger measures could offer additional protection to people who received it. The recall covers more than 2.5 million bottles.